FedCircuitBlog

Here is an update on recent en banc activity at the Federal Circuit in patent cases. Highlights include a new response to a petition raising questions concerning inducement of infringement and skinny-labeling along with the denial of five petitions raising questions related to issue preclusion and public disclosures under 35 U.S.C. § 102. Here are the details.

SCOTUS Denies Review of Patent Dispute over Groundbreaking Cancer Treatment – Blake Brittain wrote an article for Reuters explaining the Supreme Court’s decision to decline review in Ono Pharmaceutical Co Ltd v. Dana-Farber Cancer Institute Inc. 

Slow down on Mandamus: Federal Circuit Refuses to Short Circuit Judge Albright’s Decision Process – On PatentlyO.com, Dennis Crouch posted about another mandamus venue case arriving at the Federal Circuit from Judge Albright’s Waco, Texas courtroom. 

Here’s the latest.

This morning the Federal Circuit issued a nonprecedential order denying a petition for a writ of mandamus seeking to order the United States District Court for the Western District of Texas to stay all non-venue proceedings until ruling on a motion to dismiss or transfer. Here is language from the opinion.

Today the Federal Circuit issued two nonprecedential Rule 36 judgments. Here is a list of the Rule 36 judgments.